Ipca is one of the biggest manufacturers in the world of APIs Atenolol (Antihypertensive ... formulations for developed market and bio-equivalence studies of the same.During the FY 2015, the ...

In 2010, the largest portion (28%) of AstraZeneca’s revenue came from its cardiovascular drugs, including Crestor (rosuvastatin calcium), plendil (felodipine) and tenormin (atenolol), which also ...

Shareholders can now choose between $5 cash or $3 plus a $6.84 CVR in amended deal terms. All regulatory approvals have been received, and the transaction is expected to close promptly. Don’t ...

REHOVOT, Israel, April 21, 2025 /PRNewswire/ --Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and ...

For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. In a revised merger agreement, Carlyle and SK Capital Partners are now ...

SAN DIEGO--(BUSINESS WIRE)--Creyon Bio, Inc. (“Creyon”) today announced a global licensing and multi-target research collaboration with Eli Lilly and Company (“Lilly”) focused on the ...

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio. Oligonucleotides work as ...

Magill joined the banking and super watchdog after “a long career with Macquarie” in London and New York, APRA wrote in her bio on its website and in a media release. Her most recent gig at ...

Granite Bio is ready to rock 'n' roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting several autoimmune diseases. The funding consists of a $30 million series ...

Tidbits: Was a second-team AP All-American and third-team all-Big Ten last season. … Spent his first three college seasons at Michigan State but transferred and became a significant contributor ...